X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Fresenius Kabi Onco. Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Fresenius Kabi Onco. Quarterly Results   (DBPH)

Here are the latest quarterly results of Fresenius Kabi Onco.. For more details, see the Fresenius Kabi Onco. financial fact sheet and Fresenius Kabi Onco. share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Fresenius Kabi Onco. Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-11
3
Mar-12
3
Jun-12
3
Sep-12
3
Dec-12
3
Mar-13
3
Jun-13
3
Sep-13
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,2841,2181,3351,6452,0509321,269961 
Other income Rs m41657729550 
Turnover Rs m1,2881,2191,3411,6502,1279611,324961 
Expenses Rs m1,1471,0781,1121,1651,4378191,1841,250 
Gross profit Rs m13614022448061311385585 
Depreciation Rs m6361626467656975 
Interest Rs m165907300073 
Profit before tax Rs m61211683486237771437 
Tax Rs m17303779140872311 
Profit after tax Rs m44-9131269483-1048426 
Gross profit margin %10.611.516.829.229.912.16.760.9 
Effective tax rate %27.9142.922.022.722.5113.032.42.5 
Net profit margin %3.4-0.79.816.423.6-1.13.844.3 
Diluted EPS Rs 0.3 -0.1 0.8 1.7 3.1 -0.1 0.3 2.7  
Diluted EPS (TTM) Rs 1.6 1.4 1.6 2.7 5.5 5.5 5.0 6.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   GLENMARK PHARMA  DR. REDDYS LAB  ALKEM LABORATORIES  J.B.CHEMICALS  ELDER PHARMA  

Compare FRESENIUS KABI ONCO. With:   GLENMARK PHARMA  DR. REDDYS LAB  ALKEM LABORATORIES  J.B.CHEMICALS  ELDER PHARMA  

Compare FRESENIUS KABI ONCO. With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Views on news

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

Laurus Labs Ltd (IPO)

Dec 6, 2016

Equitymaster analyses Initial Public Offering (IPO) of Laurus Labs, one of the leading supplier of APIs for ARVs and Hepatitis C.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FRESENIUS KABI ONCO. SHARE PRICE


Jan 2, 2014 (Close)

TRACK FRESENIUS KABI ONCO.

  • Track your investment in FRESENIUS KABI ONCO. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FRESENIUS KABI ONCO.

FRESENIUS KABI ONCO. - ADCOCK INGRAM COMPARISON

COMPARE FRESENIUS KABI ONCO. WITH

MARKET STATS